My understanding of the FDA's stance is that the approval of the Registration study will hinge on the outcomes and data from the Phase 2 study. SYC has indicated that results from the study will be consistently disclosed, and that extensive preparations, including the manufacturing processes required for Registration approval, have been undertaken.
My understanding of the FDA's stance is that the approval of the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
